PyInvesting

Market research

688366.SHG Shanghai Haohai Biological Technology Co., Ltd

SHG CNY Healthcare

Latest close

26.58 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
7B
P/E ratio
45.45
Analyst target
45
Dividend yield
2.8%
Beta
0.43

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Shanghai Haohai Biological Technology Co., Ltd is currently in a long term uptrend where the price is trading 116.9% above its 200 day moving average.

From a valuation standpoint, the stock is 58.9% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 15.3.

Finally, its free cash flow fell by 18.1% to $89M since the same quarter in the previous year.

Based on the above factors, Shanghai Haohai Biological Technology Co., Ltd gets an overall score of 1/5.